Analysts/Institutional Investor Meet/Con. Call Updates

Ref: NEPHROPLUS/SE/99 November 04, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Listing Centre Through: NEAPS Sub.: Audio Recording of Investors’ Conference Call on Q2FY27 Financial Results Ref.: Regulation 30, 46(2) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, In continuation to our letter dated October 21, 2026, please find below link of the audio recording of the Investors’ Conference Call held on November 04, 2026 on the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended September 30, 2026: Link: https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/investors- analysts-meet/2026-27/Investors_Earnings_Call_Q2FY27-Audio_Recording.mp3 The said audio recording of the Conference Call has been uploaded on our website at www.nephroplus.com Kindly take the same on record. Yours faithfully, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary and Head Legal Membership No.: F9895